Review



mouse anti-glun2d  (Millipore)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Millipore mouse anti-glun2d
    Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and <t>GluN2D)</t> subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).
    Mouse Anti Glun2d, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-glun2d/product/Millipore
    Average 90 stars, based on 1 article reviews
    mouse anti-glun2d - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses"

    Article Title: Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses

    Journal: Frontiers in Aging Neuroscience

    doi: 10.3389/fnagi.2023.1152065

    Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and GluN2D) subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).
    Figure Legend Snippet: Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and GluN2D) subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).

    Techniques Used: In Vivo, Injection, Scaffolding, Western Blot, Expressing, Marker, MANN-WHITNEY



    Similar Products

    mouse anti-glun2d  (Millipore)
    90
    Millipore mouse anti-glun2d
    Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and <t>GluN2D)</t> subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).
    Mouse Anti Glun2d, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-glun2d/product/Millipore
    Average 90 stars, based on 1 article reviews
    mouse anti-glun2d - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    mouse monoclonal anti-glun2d  (Merck & Co)
    90
    Merck & Co mouse monoclonal anti-glun2d
    Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and <t>GluN2D)</t> subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).
    Mouse Monoclonal Anti Glun2d, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti-glun2d/product/Merck & Co
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-glun2d - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    mouse anti-glun2d mab5578  (Millipore)
    90
    Millipore mouse anti-glun2d mab5578
    Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and <t>GluN2D)</t> subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).
    Mouse Anti Glun2d Mab5578, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-glun2d mab5578/product/Millipore
    Average 90 stars, based on 1 article reviews
    mouse anti-glun2d mab5578 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and GluN2D) subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).

    Journal: Frontiers in Aging Neuroscience

    Article Title: Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses

    doi: 10.3389/fnagi.2023.1152065

    Figure Lengend Snippet: Molecular effects induced by in vivo striatal injection of αSyn soluble oligomers in mice at the corticostriatal synapse. (A) Post-synaptic levels of AMPAR (GluA1, GluA2, and GluA3) and NMDAR (GluN2A, GluN2B, and GluN2D) subunits and scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 42 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. Post-synaptic levels of (B) AMPAR (GluA1, GluA2, and GluA3) subunits, (C) NMDAR (GluN2A, GluN2B, and GluN2D) subunits and (E) scaffolding proteins (Rph3A and PSD95) were evaluated by Western blot in striatal TIF of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on tubulin were reported as OD% of PBS-mice. n = 5–7 mice. (D) Expression of the dopaminergic marker Tyrosine hydroxylase was evaluated by Western blot in striatal homogenates of sOligo- and PBS-injected mice 84 dpi. Protein levels normalized on GAPDH were reported as OD% of PBS-mice. n = 7 mice. (F) Representative confocal images and quantification of spine morphology analyses (spine density, spine length and spine width) of SPNs of sOligo- and PBS-injected mice 84 dpi. Scale bar: 3 μm. n = 19–22 neurons from 3 mice. Data are represented as mean ± SEM. * P < 0.05 (Student’s t -test; data with non-normal distribution were tested with Mann–Whitney test).

    Article Snippet: The primary antibodies used were: mouse anti-tubulin (1:30,000, #T9026, Sigma), rabbit anti-GAPDH (1:5,000, #sc-25778, Santa Cruz), rabbit anti-GluN2A (1:1,000, #M264, Sigma), rabbit anti-GluN2B (1:1,000, #718600, Invitrogen), mouse anti-GluN2D (1:1,000, #MAB5578, Millipore), rabbit anti-GluA1 (1:1,000, #13185, Cell Signaling), mouse anti-GluA2 (1:1,000, #75–002, Neuromab), mouse anti-GluA3 (1:1,000, #MAB5416, Millipore), polyclonal anti-Rph3A (1:2,000, Protein Tech, #11396-1-AP), mouse anti-PSD-95 (1:1,000, #K28/43, Neuromab), rabbit anti-tyrosine hydroxylase (1:10,000, #AB152, Millipore), rabbit anti-phospho-extracellular signal-regulated kinase (ERK) 44/42 (1:1,000, Cell Signaling, #9101), rabbit anti-ERK 44/42 (1:1,000, #9102, Cell Signaling), rabbit anti-phospho-cAMP responsive element binding protein (CREB) (1:1,000, #9198, Cell Signaling), and rabbit anti-CREB (1:1,000, #9197, Cell Signaling).

    Techniques: In Vivo, Injection, Scaffolding, Western Blot, Expressing, Marker, MANN-WHITNEY